Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Guidelines for the management of patients with periodontal diseases.

BIBLIOGRAPHIC SOURCE(S)

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Level 3: Patients Who Should Be Treated by a Periodontist

Any patient with:

  • Severe chronic periodontitis
  • Furcation involvement
  • Vertical/angular bony defect(s)
  • Aggressive periodontitis (formerly known as juvenile, early-onset, or rapidly progressive periodontitis)
  • Periodontal abscess and other acute periodontal conditions
  • Significant root surface exposure and/or progressive gingival recession
  • Peri-implant disease

Any patient with periodontal diseases, regardless of severity, whom the referring dentist prefers not to treat.

Level 2: Patients Who Would Likely Benefit from Comanagement by the Referring Dentist and the Periodontist

Any patient with periodontitis who demonstrates at reevaluation or any dental examination one or more of the following risk factors/indicators* known to contribute to the progression of periodontal diseases:

Periodontal Risk Factors/Indicators

  • Early onset of periodontal diseases (prior to the age of 35 years)
  • Unresolved inflammation at any site (e.g., bleeding upon probing, pus, and/or redness)
  • Pocket depths ≥ 5 mm
  • Vertical bone defects
  • Radiographic evidence of progressive bone loss
  • Progressive tooth mobility
  • Progressive attachment loss
  • Anatomic gingival deformities
  • Exposed root surfaces
  • A deteriorating risk profile

Medical or Behavioral Risk Factors/Indicators

  • Smoking/tobacco use
  • Diabetes
  • Osteoporosis/osteopenia
  • Drug-induced gingival conditions (e.g., phenytoins, calcium channel blockers, immunosuppressants, and long-term systemic steroids)
  • Compromised immune system, either acquired or drug induced
  • A deteriorating risk profile

* It should be noted that a combination of two or more of these risk factors/indicators may make even slight to moderate periodontitis particularly difficult to manage (e.g., a patient under 35 years of age who smokes).

Level 1: Patients Who May Benefit From Comanagement by the Referring Dentist and the Periodontist

Any patient with periodontal inflammation/infection and the following systemic conditions:

  • Diabetes
  • Pregnancy
  • Cardiovascular disease
  • Chronic respiratory disease

Any patient who is a candidate for the following therapies who might be exposed to risk from periodontal infection, including but not limited to the following treatments:

  • Cancer therapy
  • Cardiovascular surgery
  • Joint-replacement surgery
  • Organ transplantation

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations were based primarily on a comprehensive review of published reports as well as input from a task force comprised of periodontists from private practice and academia. In cases where the data did not appear conclusive, recommendations were based on the consensus opinion of the group.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2006 Sep

GUIDELINE DEVELOPER(S)

American Academy of Periodontology - Professional Association

SOURCE(S) OF FUNDING

American Academy of Periodontology

GUIDELINE COMMITTEE

Not stated

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Not stated

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

The following is available:

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This NGC summary was completed by ECRI Institute on December 22, 2008. The information was verified by the guideline developer on January 7, 2009.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is copyrighted by the American Academy of Periodontology.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo